63 research outputs found

    Promoting opioids, a story about how to influence medical science and opinions

    Get PDF
    Key origins of the opioid crisis in the US lie in some pharmaceutical companies’ substantial efforts to sell prescription painkillers. To legitimize opioids, the companies built up a body of medical science and opinions, and channels with which to communicate. Archival searches found 876 contracts that together provide information on how Mallinckrodt, an opioid manufacturer, attempted the ghost-management of medicine. These records—available because of litigation–involved contract research organizations, medical education and communication companies, publishers, professional societies, researchers, and other people who could be Mallinckrodt’s agents. Together, they produced and circulated scientific messages to increase physicians’ comfort with prescribing opioids. This article gives an overview of that activity, as seen in the contracts and related documents

    Clogging the machinery: the BBC's experiment in science coordination, 1949–1953

    Get PDF
    In 1949, physicist Mark Oliphant criticised the BBC’s handling of science in a letter to the Director General William Haley. It initiated a chain of events which led to the experimental appointment of a science adviser, Henry Dale, to improve the ‘coordination’ of science broadcasts. The experiment failed, but the episode revealed conflicting views of the BBC’s responsibility towards science held by scientists and BBC staff. For the scientists, science had a special status, both as knowledge and as an activity, which in their view obligated the BBC to make special arrangements for it. BBC staff, however, had their own professional procedures which they were unwilling to abandon. The events unfolded within a few years of the end of the Second World War, when social attitudes to science had been coloured by the recent conflict, and when the BBC itself was under scrutiny from the William Beveridge’s Committee. The BBC was also embarking on new initiatives, notably the revival of adult education. These contextual factors bear on the story, which is about the relationship between a public service broadcaster and the external constituencies it relies on, but must appear to remain independent from. The article therefore extends earlier studies showing how external bodies have attempted to manipulate the inner workings of the BBC to their own advantage (e.g. those by Doctor and Karpf) by looking at the little-researched area of science broadcasting. The article is largely based on unpublished archive documents

    EnvoĂ»tement : fabrique et management des leaders d’opinion

    No full text
    La quintessence du leader d’opinionLe Dr Kessel, sourire aux lĂšvres, tirĂ© Ă  quatre Ă©pingles, mĂ©decin et professeur, la cinquantaine, monte sur l’estrade. Il porte un costume qui doit ĂȘtre en crĂȘpe de coton, une chemise Ă  rayures bleues et blanches et une cravate jaune, une tenue parfaitement adaptĂ©e aux grandes chaleurs en cette journĂ©e d’étĂ© Ă  Philadelphie. Le Dr Kessel, qui a Ă©tĂ© prĂ©sentĂ© comme l’auteur de plus de 500 publications et « l’une des stars des neurosciences les plus brillantes ..

    L’extraction des donnĂ©es en marge de la santĂ©

    No full text
    Entre 2009 et 2013, l’Agence europĂ©enne des mĂ©dicaments (AEM) a homologuĂ© quarante-huit mĂ©dicaments anticancĂ©reux. Une Ă©tude rĂ©vĂšle qu’au moment de cette homologation, il n’y avait aucune preuve d’une amĂ©lioration de la qualitĂ© de vie ou d’une augmentation des chances de survie dans 65 % des usages pour lesquels ces mĂ©dicaments avaient Ă©tĂ© approuvĂ©s. Il semble que l’AEM ait fondĂ© ses homologations sur des espoirs et non sur des preuves. Il s’avĂšre que ces espoirs n’étaient justifiĂ©s que dans..

    Ghost-Managed Medicine

    No full text
    Ghost-Managed Medicine by Sergio Sismondo explores a spectral side of medical knowledge, based in pharmaceutical industry tactics and practices. Hidden from the public view, the many invisible hands of the pharmaceutical industry and its agents channel streams of drug information and knowledge from contract research organizations (that extract data from experimental bodies) to publication planners (who produce ghostwritten medical journal articles) to key opinion leaders (who are sent out to educate physicians about drugs) to patient advocacy organizations (who ventriloquize views on diseases, treatments and regulations), and onward. The goal of this ‘assemblage marketing’ is to establish conditions that make specific diagnoses, prescriptions and purchases as obvious and frequent as possible. While staying in the shadows, companies create powerful markets in which increasing numbers of people become sick and the drugs largely sell themselves. Most agents for drug companies aim to tell the truth, but the truths they tell are drawn from streams of knowledge that have been fed, channeled and maintained by the companies at every possible opportunity. Especially because those companies have concentrated influence and narrow interests, consumers and others should be concerned about how epistemic power is distributed – or ‘political economies of knowledge’ – and not just about truth and falsity of medical knowledge. In pharmaceutical companies’ ideal worlds, medical research, education and marketing would be tightly fused. Doctors trying to educate themselves would turn to companies’ agents, such as researchers and educators sponsored to spread particular messages, local sales reps hired to change doctors’ behaviour, or journalists supplied with news stories. Ghost-Managed Medicine shows that the real world of medicine is not very far from the worlds that the companies want to create. Big Pharma’s many invisible hands are busy throughout medicine, and medicine changes as a result

    Remerciements

    No full text
    Je suis ravi qu’ENS Éditions ait dĂ©cidĂ© de publier ce volume. Je remercie l’équipe d’ENS Éditions d’avoir pris l’initiative de cette publication, Laurent Dartigues d’avoir acceptĂ© le travail de direction scientifique pour ce projet et de l’avoir menĂ© Ă  bien, ainsi que pour sa rĂ©vision mĂ©ticuleuse de la traduction effectuĂ©e avec Jean-Claude Zancarini, co-directeur de la collection Gouvernement en question(s) Ă  ENS Éditions, Samantha SaĂŻdi pour sa traduction gĂ©nĂ©reuse, Mathias Girel, auteur de..

    Amoindrir et contraindre la capacitĂ© d’agir

    No full text
    Changer les habitudesBien que les mĂ©decins gĂ©nĂ©ralistes parviennent Ă  se leurrer sur la finalitĂ© du dĂ©marchage –, et il est Ă©tonnant qu’ils y arrivent aussi souvent – les visiteurs mĂ©dicaux qui se rendent dans leur cabinet sont trĂšs clairement des vendeurs. Les tactiques de ces derniers peuvent prendre des formes trĂšs variĂ©es, et certaines ne ressemblent pas vraiment Ă  de la vente forcĂ©e, comme la « description dĂ©taillĂ©e » qu'ils font des mĂ©dicaments de leur portefeuille et qui offre, notamm..
    • 

    corecore